Peripheral neurotoxicity induced by albumin-bound paclitaxel: a case report
The regimen containing liposomal paclitaxel, cisplatin, and tislelizumab alleviated the symptoms of peripheral neurotoxicity induced by albumin-bound paclitaxel in an NSCLC case, which may be a potential therapeutic option.
Authors
- Dunyao Bai
- Liuting Wu (ORCID: https://orcid.org/0009-0002-0403-7268)
- Xiaojing Li (ORCID: https://orcid.org/0000-0003-0454-5916)
- Juan Li (ORCID: https://orcid.org/0000-0002-0121-7098)
Institutions
- Hubei Cancer Hospital (CN)
- Wuhan University of Science and Technology (CN)
- Huazhong University of Science and Technology (CN)
Publication Details
- Journal
- Frontiers in Oncology
- Published
- 2024-09-04
- DOI
- https://doi.org/10.3389/fonc.2024.1440205
- Citations
- 2
- Primary Topic
- Cancer Treatment and Pharmacology
- Type
- article
- Field-Weighted Citation Impact
- 0.57